BIOGEN INC (BIIB) Stock Analyst Earnings Estimates
NASDAQ:BIIB - Nasdaq - US09062X1037 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 10.982B -18.32% | 10.173B -7.37% | 9.836B -3.32% | 9.832B -0.04% | 9.717B -1.17% | 9.924B 2.13% | 10.163B 2.41% | 10.441B 2.74% | 10.69B 2.38% | 10.893B 1.90% | 10.966B 0.67% | 11.396B 3.92% | |
| EBITDA YoY % growth | 3.983B -26.68% | 3.742B -6.03% | 2.669B -28.68% | 3.642B 36.45% | 3.702B 1.65% | 3.795B 2.51% | 5.151B 35.73% | 4.594B -10.81% | 3.193B -30.50% | 2.894B -9.36% | 2.939B 1.55% | 3.142B 6.91% | |
| EBIT YoY % growth | 3.495B -29.75% | 3.224B -7.75% | 2.174B -32.56% | 3.091B 42.16% | 3.101B 0.32% | 3.196B 3.06% | 3.378B 5.69% | 3.571B 5.71% | 3.513B -1.62% | 3.53B 0.48% | 3.303B -6.43% | 3.269B -1.03% | |
| Operating Margin | 31.82% | 31.69% | 22.11% | 31.44% | 31.91% | 32.20% | 33.24% | 34.20% | 32.86% | 32.41% | 30.12% | 28.69% | |
| EPS YoY % growth | 19.18 -41.56% | 18.45 -3.81% | 15.08 -18.27% | 16.71 10.84% | 17.06 2.06% | 18.14 6.35% | 19.34 6.61% | 20.41 5.51% | 20.70 1.43% | 21.29 2.84% | 22.43 5.37% | 22.98 2.46% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | 3.48 5.43% | 4.00 9.09% | 4.38 -17.09% | 4.15 1.68% | 4.25 22.22% |
| Revenue Q2Q % growth | 2.46B 3.09% | 2.377B 3.78% | 2.437B -1.13% | 2.431B -1.42% | 2.458B -0.08% |
| EBITDA Q2Q % growth | 852.57M -15.32% | 901.83M 13.59% | 964.61M -10.66% | 973.23M -7.15% | 1.023B 19.99% |
| EBIT Q2Q % growth | 658.74M 28.66% | 710.92M 9.98% | 781.82M 1.10% | 732.51M 31.04% | 728.57M 10.60% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 4.08 -6.42% | 3.87 | 0.21 | 5.50% |
| Q2 2024 Q2Q % growth | 5.28 31.34% | 4.11 | 1.17 | 28.61% |
| Q1 2024 Q2Q % growth | 3.67 7.94% | 3.52 | 0.15 | 4.32% |
| Q4 2023 Q2Q % growth | 3.30 -18.52% | 3.25 | 0.05 | 1.62% |
| Q3 2023 Q2Q % growth | 4.36 -8.60% | 4.05 | 0.31 | 7.59% |
| Q2 2023 Q2Q % growth | 4.02 -23.43% | 3.84 | 0.18 | 4.66% |
| Q1 2023 Q2Q % growth | 3.40 -22.37% | 3.34 | 0.06 | 1.66% |
| Q4 2022 Q2Q % growth | 4.05 19.47% | 3.55 | 0.50 | 13.99% |
| Q3 2022 Q2Q % growth | 4.77 | 4.22 | 0.55 | 13.06% |
| Q2 2022 Q2Q % growth | 5.25 -7.57% | 4.14 | 1.11 | 26.66% |
| Q1 2022 Q2Q % growth | 4.38 -17.98% | 4.47 | -0.09 | -1.93% |
| Q4 2021 Q2Q % growth | 3.39 -25.98% | 3.45 | -0.06 | -1.66% |
| Q3 2021 Q2Q % growth | 4.77 -46.04% | 4.17 | 0.60 | 14.44% |
| Q2 2021 Q2Q % growth | 5.68 -44.64% | 4.63 | 1.05 | 22.64% |
| Q1 2021 Q2Q % growth | 5.34 -41.58% | 5.14 | 0.20 | 3.81% |
| Q4 2020 Q2Q % growth | 4.58 -45.08% | 4.97 | -0.39 | -7.80% |
| Q3 2020 Q2Q % growth | 8.84 -3.60% | 8.20 | 0.64 | 7.80% |
| Q2 2020 Q2Q % growth | 10.26 12.13% | 8.19 | 2.07 | 25.23% |
| Q1 2020 Q2Q % growth | 9.14 30.95% | 7.89 | 1.25 | 15.88% |
| Q4 2019 Q2Q % growth | 8.34 | 8.18 | 0.16 | 1.93% |
| Q3 2019 Q2Q % growth | 9.17 | 8.44 | 0.73 | 8.69% |
| Q2 2019 Q2Q % growth | 9.15 | 7.68 | 1.47 | 19.13% |
| Q1 2019 Q2Q % growth | 6.98 | 7.00 | -0.02 | -0.33% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 2.466B -2.54% | 2.483B | -17M | -0.68% |
| Q2 2024 Q2Q % growth | 2.465B 0.36% | 2.429B | 35.9M | 1.48% |
| Q1 2024 Q2Q % growth | 2.291B -7.00% | 2.358B | -67.5M | -2.86% |
| Q4 2023 Q2Q % growth | 2.386B -6.20% | 2.514B | -127.7M | -5.08% |
| Q3 2023 Q2Q % growth | 2.53B 0.87% | 2.446B | 84.3M | 3.45% |
| Q2 2023 Q2Q % growth | 2.456B -5.14% | 2.412B | 44M | 1.82% |
| Q1 2023 Q2Q % growth | 2.463B -2.72% | 2.389B | 74M | 3.10% |
| Q4 2022 Q2Q % growth | 2.544B -6.94% | 2.491B | 53M | 2.13% |
| Q3 2022 Q2Q % growth | 2.509B -9.73% | 2.518B | -9.5M | -0.38% |
| Q2 2022 Q2Q % growth | 2.589B -6.70% | 2.522B | 67.1M | 2.66% |
| Q1 2022 Q2Q % growth | 2.532B -6.02% | 2.551B | -19.2M | -0.75% |
| Q4 2021 Q2Q % growth | 2.734B -4.16% | 2.669B | 64.8M | 2.43% |
| Q3 2021 Q2Q % growth | 2.779B -17.69% | 2.724B | 54.9M | 2.02% |
| Q2 2021 Q2Q % growth | 2.775B -24.63% | 2.657B | 118M | 4.44% |
| Q1 2021 Q2Q % growth | 2.694B -23.78% | 2.707B | -13M | -0.48% |
| Q4 2020 Q2Q % growth | 2.853B -22.30% | 2.856B | -3.4M | -0.12% |
| Q3 2020 Q2Q % growth | 3.376B -6.22% | 3.406B | -29.9M | -0.88% |
| Q2 2020 Q2Q % growth | 3.682B 1.79% | 3.497B | 184.6M | 5.28% |
| Q1 2020 Q2Q % growth | 3.534B 1.28% | 3.475B | 59.3M | 1.71% |
| Q4 2019 Q2Q % growth | 3.671B | 3.608B | 63.3M | 1.75% |
| Q3 2019 Q2Q % growth | 3.6B | 3.61B | -9.9M | -0.27% |
| Q2 2019 Q2Q % growth | 3.617B | 3.544B | 72.7M | 2.05% |
| Q1 2019 Q2Q % growth | 3.49B | 3.463B | 26.8M | 0.77% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -14.65% | 0% | 1.49% |
| Revenue | 0% | 0.78% | 0% | 0.03% |